Doxycycline is a tetracycline antibacterial with useful tissue and intracellular penetration. It is widely used for vector-borne bacterial diseases, feline hemoplasmosis and selected respiratory infections. A distinct role in canine heartworm treatment is reduction of Wolbachia, the bacterial endosymbiont associated with Dirofilaria immitis, as part of a broader parasite-treatment protocol.
Group
Tetracycline antibacterial
Mechanism of Action
Doxycycline reversibly binds the bacterial 30S ribosomal subunit and prevents aminoacyl-transfer RNA from accessing the acceptor site. This interrupts peptide-chain elongation and protein synthesis, usually producing bacteriostatic activity. Intracellular distribution supports treatment of susceptible rickettsial and related pathogens. Suppression of Wolbachia impairs bacterial support of heartworms and can reduce inflammatory consequences associated with parasite death.
Dose Rates
Dog
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Bacterial infection | 5 mg/kg | PO, IV | Every 12 h | |
| Bacterial infection | 10 mg/kg | PO | Every 24 h | |
| Rickettsial infection | 5 mg/kg | PO | Every 12 h | |
| Ehrlichiosis | 5 mg/kg | PO | Every 12 h | At least 14 days; studies describe 3–4-week courses. |
| Heartworm adjunct | 10 mg/kg | PO | Every 12 h | Up to 28 days; Wolbachia-directed course before adulticide treatment, within the complete heartworm protocol. |
| Toxoplasmosis | 5–10 mg/kg | PO | Every 12 h | Up to 28 days |
| Granulocytic anaplasmosis | 5 mg/kg | PO | Every 12 h | Up to 14 days |
| Salmon poisoning disease | 10 mg/kg | IV | Every 12 h | At least seven days; Neorickettsia helminthoeca. |
| Antiarthritic adjunct | 3–4 mg/kg | PO | Every 24 h | Up to 10 days; Reported course 7–10 days. |
Cat
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Bacterial infection | 5 mg/kg | PO, IV | Every 12 h | |
| Bacterial infection | 10 mg/kg | PO | Every 24 h | |
| Hemoplasmosis | 10 mg/kg | PO | Every 24 h | Up to 7 days |
| Chlamydial or mycoplasmal infection | 10–15 mg/kg | PO | Every 24 h | |
| Chlamydial or mycoplasmal infection | 5 mg/kg | PO | Every 12 h | |
| Systemic bacterial infection | 5–11 mg/kg | PO, IV | Every 12 h | |
| Ehrlichiosis or anaplasmosis | 5–10 mg/kg | PO | Every 12 h | Up to 21 days |
| Toxoplasmosis | 5–10 mg/kg | PO | Every 12 h | Up to 28 days |
Bird
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Bacterial infection | 25 mg/kg | PO | Every 12 h | Up to 21 days |
| Drinking-water medication | Reference only | PO | 400 mg doxycycline hyclate per liter as the sole drinking water source; actual intake varies, so this is not a direct mg/kg calculation. | |
| Chlamydiosis | 35 mg/kg | PO | Every 24 h | Up to 21 days; Experimentally infected cockatiels; oral suspension delivered into the crop. This study course is not interchangeable with other avian protocols. |
| Chlamydiosis | 40–50 mg/kg | PO | Every 24 h | Cockatiels, Senegal parrots, blue-fronted and orange-winged Amazons; conventional treatment course is 45 days. |
| Chlamydiosis | 25 mg/kg | PO | Every 24 h | African grey parrots, Goffin cockatoos, blue-and-gold and green-winged macaws; conventional treatment course is 45 days. |
| Injectable chlamydiosis course | Reference only | IM | 75–100 mg/kg every 5–7 days for four weeks, then every five days through a 45-day course. Alternative weekly regimens use 100 mg/kg, or 75 mg/kg in macaws and lovebirds, with the specified avian injectable product. Injectable preparations are not automatically interchangeable. |
Horse
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Bacterial infection | 20 mg/kg | PO | Every 12 h | Do not use in: IV administration |
| Lawsonia intracellularis infection | 20 mg/kg | PO | Every 24 h | Up to 21 days |
| Granulocytic anaplasmosis | 10 mg/kg | PO | Every 12 h | Up to 14 days; Alternative to oxytetracycline; reported course 10–14 days. Do not use IV doxycycline in horses. |
Chinchilla
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Susceptible bacterial infection | 2.5–5 mg/kg | PO | Every 12 h | Do not use in: Young growing animals, Pregnancy |
Gerbil
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Susceptible bacterial infection | 2.5–5 mg/kg | PO | Every 12 h | Do not use in: Young growing animals, Pregnancy |
Guinea Pig
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Susceptible bacterial infection | 2.5–5 mg/kg | PO | Every 12 h | Do not use in: Young growing animals, Pregnancy |
Hamster
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Susceptible bacterial infection | 2.5–5 mg/kg | PO | Every 12 h | Do not use in: Young growing animals, Pregnancy |
Mouse
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Susceptible bacterial infection | 2.5–5 mg/kg | PO | Every 12 h | Do not use in: Young growing animals, Pregnancy |
| Mycoplasmal pneumonia | Reference only | PO | Doxycycline 5 mg/kg every 12 hours with enrofloxacin 10 mg/kg every 12 hours. |
Rat
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Susceptible bacterial infection | 2.5–5 mg/kg | PO | Every 12 h | Do not use in: Young growing animals, Pregnancy |
| Mycoplasmal pneumonia | Reference only | PO | Doxycycline 5 mg/kg every 12 hours with enrofloxacin 10 mg/kg every 12 hours. |
Ratite
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Susceptible bacterial infection | 2–3.5 mg/kg | PO | Every 12 h |
Reptile
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Susceptible bacterial infection | 10 mg/kg | PO | Every 24 h | Up to 45 days; Described courses range from 10–45 days; tortoise suspected mycoplasmal respiratory infection uses four weeks. |
Indications
- Treatment of susceptible canine ehrlichiosis, anaplasmosis, rickettsiosis and Lyme borreliosis.
- Treatment of feline hemoplasmosis caused by susceptible hemotropic Mycoplasma species.
- Treatment of Chlamydia felis-associated conjunctivitis and selected Mycoplasma respiratory infections in cats.
- Treatment of selected susceptible bacterial respiratory or soft-tissue infections in dogs and cats, including some Bordetella infections.
- Reduction of Wolbachia during treatment of canine heartworm disease as part of a complete heartworm protocol.
- Treatment of selected vector-borne bacterial infections in horses, including equine granulocytic anaplasmosis.
Contraindications
- Never administer IV to horses.
- Do not inject IM or SC.
- Avoid during pregnancy when alternatives are suitable.
Interactions
- Aluminum, iron, calcium and other cations may reduce absorption.
Adverse effects
- Vomiting, diarrhea and enteritis
- Esophagitis and stricture after dry tablets/capsules in cats
- Fatal reactions with equine IV use
Preparations
| Preparation | Form | Strength | Route |
|---|---|---|---|
| Doxycycline 20 mg | Tablet | 20 mg / tablet | PO |
| Doxycycline 50 mg | Tablet | 50 mg / tablet | PO |
| Doxycycline 75 mg | Tablet | 75 mg / tablet | PO |
| Doxycycline 100 mg | Tablet | 100 mg / tablet | PO |
| Doxycycline 150 mg | Tablet | 150 mg / tablet | PO |
| Doxycycline 50 mg capsule | Capsule | 50 mg / capsule | PO |
| Doxycycline 100 mg capsule | Capsule | 100 mg / capsule | PO |
| Doxycycline oral suspension 10 mg/mL | Oral Liquid | 10 mg / mL | PO |
| Doxycycline injection 100 mg vial Doxycycline-equivalent content; reconstitute and further dilute. Never use IV in horses. | Injection | 100 mg / vial | IV |
| Doxycycline injection 200 mg vial Reconstitute and further dilute. Never IM/SC or IV in horses. | Injection | 200 mg / vial | IV |
Monitoring and Administration
Always follow feline solid oral doses with water or food. Hyclate is particularly irritating if retained in the esophagus.
For IV use in suitable species, reconstitute then further dilute, commonly to 1 mg/mL, and infuse over 1–2 hours.
Monitor response and use susceptibility testing for ordinary bacterial infections; Enterobacterales and Pseudomonas are often resistant.
Aqueous compounded suspension stability is formulation dependent and can be short; a particular Ora-Plus/Ora-Sweet mixture retained potency for only 7 days. Darkening can indicate degradation.